Skip to main content
Caplight Logo









RNAissance

RNAissance

Private
United StatesHealthcare & Life Scienceshttps://rnaissance.bio

Company Overview

RNAissance operates in Healthcare & Life Sciences and is based in the United States.

RNAissance is a biotechnology company developing a new class of therapeutics that directly modulate disease-driving RNA–protein interactions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

RNAissance Comparables

Compare RNAissance with similar companies based on industry and business-model similarity.

RNAissance comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innatrix, Inc.
87%
NanoSUR
86%
Trillium Ag
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

RNAissance Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for RNAissance. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

RNAissance Filings

Explore SEC and related filing metadata, where available.

RNAissance filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about RNAissance's valuation, stock price, and market status.

Is RNAissance a public or private company?

RNAissance is a private company.

What is the current stock price of RNAissance?

RNAissance is a private company, so its shares have no public market price. Caplight tracks RNAissance's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RNAissance worth (valuation)?

Valuation information for RNAissance is not publicly available.

Can I buy RNAissance stock?

RNAissance shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RNAissance's last funding round?

Funding round information for RNAissance is not publicly available.

Who are the main investors in RNAissance?

Investor information for RNAissance is not publicly disclosed.

Will RNAissance IPO soon?

No public IPO plans have been announced for RNAissance.

How can I track RNAissance secondary market activity?

Caplight tracks bids, offers, and trades in RNAissance's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?